Mianserin Hydrochloride - CAS 21535-47-7
Catalog number: 21535-47-7
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C18H20N2.HCl
Molecular Weight:
300.83
COA:
Inquire
Targets:
Histamine Receptor
Description:
Mianserin Hydrochloride is a psychoactive drug of the tetracyclic antidepressant.It is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA) and has antidepressant, anxiolytic (anti-anxiety), hypnotic (sedating), antiemetic (nausea and vomiting-attenuating), orexigenic (appetite-stimulating), and antihistamine effects.It is not approved for use in the US.
Purity:
>98%
Synonyms:
ORG GB-94 HCl; Mianserin hydrochloride; Tolvon; Tolvin; ORG GB 94; Lerivon.
MSDS:
Inquire
InChIKey:
YNPFMWCWRVTGKJ-UHFFFAOYSA-N
InChI:
InChI=1S/C18H20N2.ClH/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19;/h2-9,18H,10-13H2,1H3;1H
Canonical SMILES:
CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42.Cl
1.In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay
Ellen A. Walker & Edward K. Brown Jr. & Steven N. Sterious. Psychopharmacology (2007) 193:187–197
The following drugs were used: BW723C86 hydrochloride, cyproheptadine hydrochloride,mCPP dihydrochloride, ketan-serin tartrate, metergoline phenylmethyl ester, methysergide maleate, mianserin hydrochloride,MK212 hydrochloride, SB 200,646 hydrochloride [N-(1-Methyl-1H-indol-5-yl)-N’-(3-pyridinylurea hydrochloride], SB 204,741 [N-(1-Methyl-1H-indol-5-yl)-N’-(3-methyl-5-isothiazolyl)urea], RS102221 hydrochloride (Tocris Bioscience, Ellisville, MO), (+)-2-bromolysergic acid diethylamide hydrogen tartrate (BOL), morphine sulfate, and naltrexone hydrochloride (generously supplied by the National Institute on Drug Abuse, Rockville, MD). SB 200,646 and SB 204,741 were initially dissolved in a few drops of 8.5% lactic acid and sterile water. Higher concentrations of SB 200,646 and SB 204,741 required sonication just before injection to maintain a solution. All other drugs were dissolved in sterile water. Injections were administered s.c. in the dorsal flank in a volume of 0.5–1.0 ml/kg. Drug doses for all drugs except SB 204,741 are expressed based on milligrams per kilogram of the salt.
2.Management of non-motor complications in Parkinson’s disease
Ken-ichi Fujimoto. J Neurol (2009) 256 (Suppl 3):S299–S305
Selegiline (5 mg), cabergoline (2 mg), and pergolide (1.5 mg) were withdrawn in that order, but the hallucinations/delusions were unchanged. Then the dose of L-dopa/DCI was reduced from 600 to 150 mg after 1 month and mianserin hydrochloride (30 mg) was added. Motor complications were aggravated and she had difficulty walking, but the delusions were unchanged. When a patient believes his/her delusions, the problem may not be detected, as occurred in this case. When delusions are untreated for a long time, progression to paranoia occurs and the condition becomes untreatable. Patients should be questioned during routine examination to detect the presence of psychosis and enable early diagnosis. Because disuse syndrome develops when aggravation of motor symptoms is not treated, subsequent actions should be taken immediately if adjustment of medications is not effective. Modified electroconvulsive therapy (mECT) was immediately performed in this patient. Her delusions completely subsided after mECT was done a total of seven times at a frequency of three times weekly. Then her drug therapy was altered and the state before the development of psychosis was finally restored with L-dopa/DCI (650 mg) and mianserin hydrochloride (20 mg) after dinner.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products


CAS 1056596-82-7 Mizolastine dihydrochloride

Mizolastine dihydrochloride
(CAS: 1056596-82-7)

The dihydrochloride salt form of Mizolastine which is effective in the treatment of seasonal allergic rhinitis, perennial allergic rhinitis and other allergy sy...

CAS 113-92-8 Chlorpheniramine Maleate

Chlorpheniramine Maleate
(CAS: 113-92-8)

Chlorpheniramine inhibits the proliferation of MCF-7, MDA-MB 231, and Ehrlich cells in a dose-response manner, and significantly reduces the ornithine decarboxy...

CAS 195867-54-0 HTMT dimaleate

HTMT dimaleate
(CAS: 195867-54-0)

HTMT dimaleate is a histamine H1 and H2 receptor agonist with 4x104 fold activity over histamine in H2-mediated effects in natural suppressor cells. HTMT dimale...

CAS 720691-69-0 GSK-239512

GSK-239512
(CAS: 720691-69-0)

GSK-239512 is a histamine H3 receptor antagonist. In Jun 2015, Phase-II for Schizophrenia in USA was discontinued. Phase II clinical trilas for the treatment of...

CAS 639089-06-8 VUF 5681 dihydrobromide

VUF 5681 dihydrobromide
(CAS: 639089-06-8)

VUF 5681 dihydrobromide is a potent histamine H3 receptor silent antagonist (pKi = 8.35).

CAS 154-69-8 Tripelennamine hydrochloride

Tripelennamine hydrochloride
(CAS: 154-69-8)

Tripelennamine hydrochloride, the hydrochloride salt form of tripelennamine, is a blood-brain barrier penetrant and orally active H1 receptor antagonist. Tripel...

CAS 76496-69-0 Levoprotiline hydrochloride

Levoprotiline hydrochloride
(CAS: 76496-69-0)

Levoprotiline is a Histamine H1 receptor antagonist originated by Novartis. It is an antidepressant. But clinical trials for Major depressive disorder were disc...

CAS 34839-70-8 Metiamide

Metiamide
(CAS: 34839-70-8)

Metiamide is developed from another burimamide, used as a histamine H2 receptor antagonist.

Chemical Structure

CAS 21535-47-7 Mianserin Hydrochloride

Quick Inquiry

Verification code

Featured Items